Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$58.05 - $111.31 $11.2 Million - $21.5 Million
-192,986 Closed
0 $0
Q2 2020

Aug 03, 2020

BUY
$57.2 - $74.41 $159,130 - $207,008
2,782 Added 1.46%
192,986 $11.4 Million
Q1 2020

May 06, 2020

BUY
$57.05 - $95.75 $10.9 Million - $18.2 Million
190,204 New
190,204 $12.8 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.63B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Redwood Investments, LLC Portfolio

Follow Redwood Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Investments, LLC with notifications on news.